Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

AddLife

179.70 SEK

-1.75 %

Less than 1K followers

ALIF B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
-1.75 %
-9.70 %
+1.07 %
-6.31 %
+30.88 %
+30.69 %
+51.77 %
+42.10 %
+656.50 %

AddLife operates in the medical technology industry and focuses on the development, manufacturing and distribution of medical equipment and laboratory products. The company's products are aimed at healthcare institutions and research laboratories. The business is global with a primary presence in Europe, North America and Asia. AddLife was founded in 2015 and is headquartered in Stockholm, Sweden.

Read more
Market cap
22B SEK
Turnover
8.84M SEK
Revenue
10.29B
EBIT %
7.01 %
P/E
87.23
Dividend yield-%
0.42 %
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
4/2
2026

Annual report '25

28/4
2026

Interim report Q1'26

6/5
2026

General meeting '26

All
Webcasts
Press releases
3rd party
ShowingAll content types
Press release12/1/2025, 2:00 PM

AddLife förvärvar Opitek International ApS

AddLife
Press release12/1/2025, 2:00 PM

AddLife acquires Opitek International ApS

AddLife
Press release12/1/2025, 1:00 PM

AddLife förvärvar Pharmacold A/S

AddLife

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release12/1/2025, 1:00 PM

AddLife acquires Pharmacold A/S

AddLife
Regulatory press release11/14/2025, 9:47 AM

Finansinspektionen: Flaggningsmeddelande i AddLife AB

AddLife
Regulatory press release11/4/2025, 2:58 PM

Finansinspektionen: Flaggningsmeddelande i AddLife AB

AddLife
Regulatory press release10/23/2025, 5:45 AM

Delårsrapport 1 januari – 30 september 2025

AddLife
Regulatory press release10/23/2025, 5:45 AM

Interim Report January 1 – September 30, 2025

AddLife
Regulatory press release7/15/2025, 5:45 AM

Delårsrapport 1 januari – 30 juni 2025

AddLife
Regulatory press release7/15/2025, 5:45 AM

Interim Report January 1 – June 30, 2025

AddLife
Regulatory press release6/2/2025, 6:23 AM

Finansinspektionen: Flaggningsmeddelande i AddLife AB

AddLife
Regulatory press release5/8/2025, 3:45 PM

Årsstämma i AddLife AB den 8 maj 2025

AddLife
Regulatory press release5/8/2025, 3:45 PM

Annual General Meeting of AddLife AB 8 May 2025

AddLife
Regulatory press release4/25/2025, 5:45 AM

Margin improvement continues, the debt level is reduced, and acquisition activity increases

AddLife
Regulatory press release4/25/2025, 5:45 AM

Marginalförbättringen fortsätter, skuldsättningen minskar och förvärvsaktiviteten ökar

AddLife
Regulatory press release4/4/2025, 7:00 AM

AddLifes årsredovisning för 2024 offentliggjord

AddLife
Regulatory press release4/4/2025, 7:00 AM

AddLife's Annual Report for 2024 is now published

AddLife
Press release4/1/2025, 1:00 PM

AddLife förvärvar Edge Medical Ltd

AddLife
Press release4/1/2025, 1:00 PM

AddLife acquires Edge Medical Ltd

AddLife
Regulatory press release3/27/2025, 10:00 AM

Notice to attend the Annual General Meeting of AddLife AB (publ)

AddLife
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.